Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell carcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell carcinoma.
A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell carcinoma. Cancer Chemother Pharmacol. 2008 Apr; 61(4):689-94.
View in:
PubMed
subject areas
Adult
Aged
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Capecitabine
Carcinoma, Renal Cell
Deoxycytidine
Disease Progression
Female
Fluorouracil
Humans
Infusions, Intravenous
Kidney Neoplasms
Male
Middle Aged
Oligodeoxyribonucleotides
Reverse Transcriptase Polymerase Chain Reaction
Survival Analysis
authors with profiles
Walter M. Stadler